FOXO TECHNOLOGIES INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
FOXO TECHNOLOGIES INC. (FOXO) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $913.22 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $913.22K.
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $9.64M.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $11.08M.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $20.14M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2026-06-30 | $913.22K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $9.64M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $11.08M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $20.14M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $13.68M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $9.65M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $5.27M 10-Q · filed 2026-08-14 | |
| 2024-12-16 | -$4.00M 10-K · filed 2025-04-15 | |
| 2024-09-30 | -$17.55M 10-Q · filed 2025-11-10 | -$17.55M 10-Q · filed 2024-11-19 |
| 2024-06-30 | -$16.17M 10-Q · filed 2025-11-10 | -$16.17M 10-Q · filed 2024-08-19 |
| 2024-03-31 | -$14.94M 10-Q · filed 2025-11-10 | -$14.94M 10-Q · filed 2024-08-19 |
| 2023-12-31 | -$14.10M 10-K · filed 2026-04-15 | -$14.10M 10-Q · filed 2024-08-19 |
| 2023-06-30 | -$7.03M 10-Q · filed 2024-08-19 | |
| 2022-12-31 | $6.71M 10-K · filed 2025-04-15 | $6.71M 10-Q · filed 2024-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |